FBLN2 and Myocardial fibrosis: Lastly, fibulins—especially circulating Fibulin-2—are suggested to correlate with myocardial fibrosis in HCM, adding further value to the pool of ECM-related biomarkers in cardiac disease management (Ibrahim et al., 2020a).